Ozonoterapia epidural con mezcla de O₂–O₃ para el manejo del dolor asociado a enfermedades toracolumbares degenerativas en perros: reporte de dos casos clínicos
Ozone Therapy Global Journal · 22.06.2026 · 15 (1) · 69-81
DOI: 10.67442/dasvhw09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ozone Therapy Global Journal, online erschienen am 22.06.2026. Verfasst von Otto Leonidas Lima Lucero.
Abstract (Originalsprache)
A descriptive observational study of two cases was conducted to evaluate the effect of epidural oxygen-ozone (O₂-O₃) injection in dogs with chronic debilitating pain and degenerative thoracolumbar diseases. Materials and methods: Two dogs were treated with epidural injection of an O₂-O₃ mixture at a concentration of 5 µg/ml and a volume of 2 to 3 ml after being clinically diagnosed with acute or chronic thoracolumbar pain associated with radiologically evidenced spondylosis. Results: Within 48 hours of treatment, a significant improvement in pain was observed. Both dogs recovered gait function, and no recurrence was observed. It is concluded that epidural injection of O2-O3 can contain pain, manage neurological signs, and decompress the affected discs
Zitieren
APA
Lucero, O. L. L. (2026). Ozonoterapia epidural con mezcla de O₂–O₃ para el manejo del dolor asociado a enfermedades toracolumbares degenerativas en perros: reporte de dos casos clínicos. Ozone Therapy Global Journal, 15(1), 69-81. https://doi.org/10.67442/dasvhw09
Vancouver
Lucero OLL. Ozonoterapia epidural con mezcla de O₂–O₃ para el manejo del dolor asociado a enfermedades toracolumbares degenerativas en perros: reporte de dos casos clínicos. Ozone Therapy Global Journal. 2026;15(1):69-81. doi:10.67442/dasvhw09
BibTeX
@article{Lucero2026,
author = {Lucero, Otto Leonidas Lima},
title = {Ozonoterapia epidural con mezcla de O₂–O₃ para el manejo del dolor asociado a enfermedades toracolumbares degenerativas en perros: reporte de dos casos clínicos},
journal = {Ozone Therapy Global Journal},
year = {2026},
volume = {15},
number = {1},
pages = {69--81},
doi = {10.67442/dasvhw09}
}
EUVIMED